The economic cost of brain disorders in Europe
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2011/12/19
-
Journal
-
Indian UGC (journal)
-
Refrences21
-
Citations943
-
J. Olesen
-
A. Gustavsson
-
M. Svensson
-
H.‐U. Wittchen
-
B. Jönsson
-
-
Abstract
Cite
Olesen, J., et al. “The Economic Cost of Brain Disorders in Europe”. European Journal of Neurology, vol. 19, no. 1, 2011, pp. 155-62, https://doi.org/10.1111/j.1468-1331.2011.03590.x.
Olesen, J., Gustavsson, A., Svensson, M., Wittchen, H., & Jönsson, B. (2011). The economic cost of brain disorders in Europe. European Journal of Neurology, 19(1), 155-162. https://doi.org/10.1111/j.1468-1331.2011.03590.x
Olesen J, Gustavsson A, Svensson M, Wittchen H, Jönsson B. The economic cost of brain disorders in Europe. European Journal of Neurology. 2011;19(1):155-62.
Journal Categories
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Neurology
Diseases of the nervous system
You May Also Like
- Prospective assessment of falls in Parkinson's disease
- The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy
- Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
- Mitochondria, oxidative stress and neurodegeneration
- Central nervous system manifestations of COVID-19: A systematic review
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Consensus document on European brain research | 2006 | |||
| The epidemiology of anxiety disorders: prevalence and societal costs | The Journal of Clinical Psychiatry |
| 2002 | |
| Do Norwegian cancer patients receive the care they deserve? | 2006 | |||
| The cost of migraine and its treatment | The American Journal of Managed Care |
| 2005 | |
| Diagnostic and Statistical Manual | 1994 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort Study | Annals of Neurology |
| 1 | 2024 |
The definition of treatment resistance in anxiety disorders: a Delphi method‐based consensus guideline | World Psychiatry |
| 3 | 2024 |
| Treatment resistance in anxiety disorders—Definition and treatment options | Der Nervenarzt |
| 2024 | |
Pathways to professional mental care in the Swiss young adult community: a case–control study | European Archives of Psychiatry and Clinical Neuroscience |
| 2024 | |
| The effect of vitamin D supplementation on primary depression: A meta-analysis | Journal of Affective Disorders |
| 2024 |
Citations Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 329
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Matrix metalloproteinase 9 and cellular fibronectin plasma concentrations are predictors of the composite endpoint of length of stay and death in the intensive care unit after severe traumatic brain injury and was published in 2012. The most recent citation comes from a 2024 study titled Health Care Utilization and Direct Costs Prior to Subspecialty Care in Children with Chronic Pain Compared with Other Chronic Childhood Diseases: A Cohort Study. This article reached its peak citation in 2016, with 106 citations. It has been cited in 524 different journals, 23% of which are open access. Among related journals, the Journal of Affective Disorders cited this research the most, with 20 citations. The chart below illustrates the annual citation trends for this article.